APP下载

阿仑膦酸钠联合甲氨喋呤治疗绝经后类风湿关节炎患者的疗效研究

2020-12-23曹赛霞

中国实用医药 2020年32期

曹赛霞

【摘要】 目的 研究阿侖膦酸钠联合甲氨喋呤治疗绝经后类风湿关节炎患者的疗效。方法 80例绝经后类风湿关节炎患者, 以治疗方式不同分为A组和B组, 每组40例。A组患者采用常规治疗, B组患者采用阿仑膦酸钠联合甲氨喋呤进行治疗。对比两组患者治疗前后视觉模拟评分法(VAS)评分以及临床治疗效果、不良反应发生情况、生活质量评分。结果 B组的治疗总有效率97.50%明显高于A组的80.00%, 差异具有统计意义(P<0.05)。治疗前, 两组患者的VAS评分比较差异无统计学意义(P>0.05);治疗后, 两组患者的VAS评分均较治疗前下降, B组的下降程度明显大于A组, 差异具有统计意义(P<0.05)。B组患者的不良反应发生率10.00%明显低于B组的27.50%, 差异具有统计意义(P<0.05)。B组患者的生理功能、躯体疼痛、社会功能、情感职能、精神健康评分均明显高于A组, 差异具有统计意义(P<0.05)。结论 使用阿仑膦酸钠联合甲氨喋呤对绝经后类风湿关节炎患者进行治疗, 可有效提高患者的临床治疗效果, 同时还能缓解患者的疼痛, 减少不良反应发生率, 值得在临床中推广应用。

【关键词】 阿仑膦酸钠;甲氨喋呤;绝经后类风湿关节炎

DOI:10.14163/j.cnki.11-5547/r.2020.32.042

【Abstract】 Objective   To study the efficacy of alendronate sodium combined with methotrexate in the treatment of postmenopausal patients with rheumatoid arthritis. Methods   A total of 80 postmenopausal patients with rheumatoid arthritis were divided into group A and group B according to different treatment methods, with 40 cases in each group. Group A was treated with conventional therapy, and group B was treated with alendronate sodium combined with methotrexate. The visual analogue scale (VAS) score, clinical effect, occurrence of adverse reactions and quality of life score were compared between the two groups. Results   The total effective rate of treatment 97.50% of group B was obviously higher than 80.00% of group A, and the difference was statistically significant (P<0.05). Before treatment, there was no statistically significant difference in VAS score between the two groups (P>0.05). After treatment, VAS score of the two groups were lower than those before treatment, and the decrease degree of group B was significantly greater than that of group A, and the difference was statistically significant (P<0.05). The incidence of adverse reactions 10.00% of group B was obviously lower than 27.50% of group B, and the difference was statistically significant (P<0.05). The physiological function, physical pain, social function, emotional function, mental health score of group B were obviously higher than those of group A, and the difference was statistically significant (P<0.05). Conclusion   Alendronate sodium combined with methotrexate can effectively improve the clinical treatment effect of postmenopausal patients with rheumatoid arthritis, but also can alleviate the pain of patients and reduce the incidence of adverse reactions, which is worthy of clinical promotion and application.

【Key words】 Alendronate sodium; Methotrexate; Postmenopausal rheumatoid arthritis

类风湿关节炎在临床中较为常见, 属于慢性进行性疾病, 发病人群多为中老年群体[1]。该病具有病程常、病情发展慢以及治疗难度大等特点, 一旦发病, 将会对患者的生活质量造成严重的影响[2]。本文选取80例绝经后类风湿关节炎患者作为研究对象进行分析, 现报告如下。

1 资料与方法

1. 1 一般资料 选取本院于2017年5月~2019年1月收治的80例绝经后类风湿关节炎患者作为研究对象。纳入标准:①经诊断确认为绝经后类风湿关节炎患者;②临床资料完整的患者。排除标准:①对本次研究药物过敏的患者;②患有严重心肺、肝肾疾病的患者。以治疗方式不同将患者分为A组和B组, 每组40例。A组患者年齡50~86岁, 平均年龄(68.33±6.11)岁;病程1~8年, 平均病程(4.25±1.25)年。B组患者年龄50~88岁, 平均年龄(69.14±6.38)岁;病程1~9年, 平均病程(4.82±1.40)年。两组患者的一般资料比较, 差异无统计学意义(P>0.05), 具有可比性。本……

登录APP查看全文